ANTIMICROBIAL SUSCEPTIBILITY OF Streptococcus agalactiae ISOLATED FROM PREGNANT WOMEN

Simone Cristina Castanho Sabaini de Melo1, Nathally Claudiane de Souza Santos2, Marcia de Oliveira2

  • 1State University of Maringá, Postgraduate Program in Health Sciences Maringá, Paraná, Brazil. E-mails: simonecastanho@uenp.edu.br; mdbcarvalho@gmail.com; smpelloso@gmail.com or smpelloso@uem.br.

Insights

Group B Streptococcus (GBS) is a risk for newborns. In Brazil, GBS isolates from pregnant women remained susceptible to penicillin, but resistance to clindamycin and erythromycin was observed, limiting alternative treatments.

Area of Science:

  • Microbiology
  • Obstetrics
  • Infectious Diseases

Background:

  • Group B Streptococcus (GBS), or Streptococcus agalactiae, colonizes the gastrointestinal and genitourinary tracts.
  • GBS is a significant risk factor for neonatal disease.

Purpose of the Study:

  • To evaluate the antimicrobial susceptibility of GBS isolates from pregnant women in Northern Paraná, Brazil.
  • To inform intrapartum antibiotic prophylaxis strategies.

Main Methods:

  • A descriptive, analytical, cross-sectional study was conducted.
  • Antimicrobial susceptibility testing was performed on 136 GBS isolates from 544 pregnant women (≥ 35 weeks gestation).

Main Results:

  • All GBS isolates demonstrated susceptibility to penicillin, the primary drug for intrapartum prophylaxis.
  • Resistance to clindamycin and erythromycin was detected in a subset of isolates.

Conclusions:

  • Penicillin remains a reliable option for GBS prophylaxis in this population.
  • Decreased susceptibility to clindamycin and erythromycin reduces alternative prophylaxis options for penicillin-allergic women.
  • Further research is needed to understand GBS sensitivity profiles in other regions.
Abstract